United StatesÚltimas notícias

Heather Conley, Nonresident Senior Fellow at AEI and Former Deputy Assistant Secretary of State for the Bureau of European and Eurasian Affairs says because Iran controls the Strait of Hormuz, they have a strategic advantage.

Jay Ritter, University of Florida emeritus professor and director of the IPO Initiative, known as "Mr. IPO" for his work on initial public offerings, joins Caroline Hyde and Ed Ludlow on "Bloomberg Tech." to discuss SpaceX's IPO. It is set to be "the largest private-sector company ever to go public," for the broader tech IPO landscape, he says.

Merck (NYSE:MRK) announced that its board of directors has formally declared a quarterly dividend of $0.85 per share.

Eli Lilly & Co. is buying three clinical-stage vaccine developers for as much as $3.8 billion, leveraging its obesity-fueled dominance to establish itself as a leader in other areas and become a major player in infectious diseases.  The agreements with Curevo, LimmaTech Biologics and Vaccine Company give Lilly access to novel technology and experimental immunizations for shingles, common bacterial pathogens and Epstein-Barr virus, according to a statement on Tuesday.  "These acquisitions reflect a deliberate strategy to prevent disease at its source rather than treat its consequences," Dan Skovronsky, Lilly's chief scientific and product officer, said in a statement.  Bloomberg News Health Reporter, Madison Muller, joins Paul Sweeney and Alexis Christoforous on "Bloomberg Intelligence" to analyze what's next for Eli Lilly after agreeing to buy three vaccine developers.

Qualcomm will supply chips to TikTok owner ByteDance for artificial intelligence data centers, according to people familiar with the matter. Ian King helped break the story and he reports on "Bloomberg Tech."

Kyivstar Group (NASDAQ:KYIV) announced the acquisition of six solar power plants in Ukraine’s Lviv region for a total consideration of UAH 3.6 billion (approximately $80.8 million), accelerating the telecommunication firm’s vertical integration into sovereign power generation to mitigate localized infrastructure risks.

Arrowhead Pharmaceuticals (NASDAQ:ARWR) unveiled new clinical data expanding the medical profile of plozasiran, its approved RNA interference (RNAi) therapeutic, demonstrating that the drug can be administered to patients suffering from moderate-to-severe renal impairment or moderate hepatic impairment without necessitating a reduction in dose.

The AI data center boom is becoming an industrial arms race. CyrusOne CEO Eric Schwartz joined Bloomberg Open Interest to explain why the future of AI depends on power grids, skilled labor, and trillion-dollar infrastructure bets.

Wall Street's AI boom is spilling into credit markets. As hyperscalers' issue huge amounts of debt, banks are buying protection to manage exposure, while hedge funds sell that protection for what looks like easy money. But if the AI race starts producing winners and losers, this quiet CDS trade could become much riskier.

Eli Lilly is developing a groundbreaking one-time gene-editing treatment that could permanently lower bad cholesterol and reduce heart disease risk. Bloomberg's Madison Muller joins Open Interest to break down the science, the risks, and why Lilly is racing to expand beyond obesity drugs into its next major growth era.

Shares of Micron Technology (NASDAQ:MU) surged to an all-time intraday high following a dramatic price target increase from UBS, which argued that the artificial intelligence infrastructure buildout has permanently altered the financial predictability and valuation framework of the memory chip industry.

Ferrari's first fully electric car is already dividing fans. Critics say the $640K EV looks more like a Nissan Leaf or "a bar of soap" than a Ferrari, but the company may not care. Bloomberg's Craig Trudell joins Open Interest to explain why Ferrari only needs a handful of wealthy buyers to make the Luce a success, and how the brand could use the EV to unlock access to future supercars.